Open Access
Subscription Access
Adrenocorticotropic hormone for steroid-resistant and oral steroid-intolerant children with minimal change nephrotic syndrome
Abstract
Background: The most frequent cause of nephrotic syndrome (NS) in childhood, minimal change disease, is generally steroid-responsive. Children who are intolerant of oral steroids or steroid-resistant still present a significant therapeutic challenge. Additionally, adverse effects of long-term corticosteroid administration warrant the search for an alternative safe and effective treatment. Here we report the use of adrenocorticotropic hormone (ACTH; H.P. Acthar® Gel), an agent originally introduced in the 1950s, for the treatment of these patients.
Methods: We report 3 children with NS who were not able to attain remission with standard steroid therapy due to oral steroid intolerance or steroid resistance.
Results: Two of the patients attained remission with a long-acting formulation of ACTH.
Conclusions: ACTH is an option for the treatment of pediatric patients with NS who are oral steroid-intolerant. This approach may also be useful for the treatment of other steroid-responsive conditions in patients with limiting gastrointestinal toxicity to oral preparations. The use of ACTH for the treatment of steroid-resistant NS requires further investigation.
References
Gipson DS, Massengill SF, Yao L, et al. Management of childhood onset nephrotic syndrome. Pediatrics 2009;124:747-57.
Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003;362:629-39.
Brown RB, Burke EC, Stickler GB. Studies in nephrotic syndrome. I. Survival of 135 children with nephrotic syndrome treated with adrenal steroids. Mayo Clin Proc 1965;40:384-90.
Heymann W, Spector S, Matthews LW, Shapiro DJ. Treatment of the nephrotic syndrome with corticotrpoin (ACTH) and cortisone: a four and one half year survey of results with short-term courses. Am J Dis Child 1955;90:22-7.
McCall MF, Ross A, Wolman B, Burns AD, Harpur EM, Goldbloom A. The nephrotic syndrome in children treated with A.C.T.H. and cortisone. Arch Dis Child 1925;27:309-21.
International Study of Kidney Disease in Children. Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the International Study of Kidney Disease in Children. J Pediatr 1979;95:239-43.
The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 1981;98:561-4.
Bomback AS, Tumlin JA, Baranski J, et al. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel. Drug Des Devel Ther 2011;5:147-53.
Bomback AS, Canetta PA, Beck LH Jr, Ayalon R, Radhakrishnan J, Appel GB. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial. Am J Nephrol 2012;36:58-67.
H.P. Acthar® Gel (repository corticotropin injection) [prescribing information]. Hayward, CA: Questcor Pharmaceuticals, Inc.; September 2012.
Refbacks
- There are currently no refbacks.
Copyright © 2013 Journal of Clinical Pediatric Nephrology